-
1
-
-
77951176799
-
Idiopathic pulmonary fibrosis: A disease with similarities and links to cancer biology
-
Vancheri C, Failla M, Crimi N, Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 2010;35:496-504.
-
(2010)
Eur Respir J
, vol.35
, pp. 496-504
-
-
Vancheri, C.1
Failla, M.2
Crimi, N.3
Raghu, G.4
-
2
-
-
79956341531
-
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials
-
Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011;377:1760-9.
-
(2011)
Lancet
, vol.377
, pp. 1760-1769
-
-
Noble, P.W.1
Albera, C.2
Bradford, W.Z.3
-
3
-
-
84901810710
-
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
-
Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2071-82.
-
(2014)
N Engl J Med
, vol.370
, pp. 2071-2082
-
-
Richeldi, L.1
Du Bois, R.M.2
Raghu, G.3
-
4
-
-
84901759236
-
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
-
King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2083-92.
-
(2014)
N Engl J Med
, vol.370
, pp. 2083-2092
-
-
King Jr., T.E.1
Bradford, W.Z.2
Castro-Bernardini, S.3
-
5
-
-
80053091084
-
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis
-
Richeldi L, Costabel U, Selman M, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med 2011;365:1079-87.
-
(2011)
N Engl J Med
, vol.365
, pp. 1079-1087
-
-
Richeldi, L.1
Costabel, U.2
Selman, M.3
-
6
-
-
34248177260
-
Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis
-
DOI 10.1183/09031936.00152106
-
Chaudhary NI, Roth GJ, Hilberg F, et al. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J 2007;29:976-85. (Pubitemid 46711904)
-
(2007)
European Respiratory Journal
, vol.29
, Issue.5
, pp. 976-985
-
-
Chaudhary, N.I.1
Roth, G.J.2
Hilberg, F.3
Muller-Quernheim, J.4
Prasse, A.5
Zissel, G.6
Schnapp, A.7
Park, J.E.8
-
7
-
-
0347996179
-
Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity
-
DOI 10.1034/j.1600-6143.2002.020201.x
-
Shihab FS, Bennett WM, Yi H, Andoh TF. Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity. Am J Transplant 2002;2:111-9. (Pubitemid 36306789)
-
(2002)
American Journal of Transplantation
, vol.2
, Issue.2
, pp. 111-119
-
-
Shihab, F.S.1
Bennett, W.M.2
Yi, H.3
Andoh, T.F.4
-
9
-
-
28144459814
-
High-dose acetylcysteine in idiopathic pulmonary fibrosis
-
DOI 10.1056/NEJMoa042976
-
Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005;353:2229-42. (Pubitemid 41697286)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.21
, pp. 2229-2242
-
-
Demedts, M.1
Behr, J.2
Buhl, R.3
Costabel, U.4
Dekhuijzen, R.5
Jansen, H.M.6
MacNee, W.7
Thomeer, M.8
Wallaert, B.9
Laurent, F.10
Nicholson, A.G.11
Verbeken, E.K.12
Verschakelen, J.13
Flower, C.D.R.14
Capron, F.15
Petruzzelli, S.16
De Vuyst, P.17
Van Den, B.J.M.M.18
Rodriguez-Becerra, E.19
Corvasce, G.20
Lankhorst, I.21
Sardina, M.22
Montanari, M.23
more..
-
10
-
-
84861394764
-
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
-
The Idiopathic Pulmonary Fibrosis Clinical Research Network
-
The Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012;366:1968-77.
-
(2012)
N Engl J Med
, vol.366
, pp. 1968-1977
-
-
-
11
-
-
84901746607
-
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis
-
The Idiopathic Pulmonary Fibrosis Clinical Research Network
-
The Idiopathic Pulmonary Fibrosis Clinical Research Network. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2014;370:2093-101.
-
(2014)
N Engl J Med
, vol.370
, pp. 2093-2101
-
-
|